financetom
Business
financetom
/
Business
/
Zurn Elkay Water Solutions Q4 Non-GAAP EPS, Revenue Climb
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zurn Elkay Water Solutions Q4 Non-GAAP EPS, Revenue Climb
Feb 4, 2025 2:28 PM

05:04 PM EST, 02/04/2025 (MT Newswires) -- Zurn Elkay Water Solutions ( ZWS ) reported Q4 non-GAAP net income Tuesday of $0.32 per diluted share, up from $0.26 a year ago.

Analysts polled by FactSet expected $0.28.

Revenue in the quarter ended Dec. 31 was $370.7 million compared with $356.8 million a year ago.

Analysts expected $366.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlantic Union Bankshares to buy Sandy Spring Bancorp in $1.6 bln deal
Atlantic Union Bankshares to buy Sandy Spring Bancorp in $1.6 bln deal
Oct 21, 2024
Oct 21 (Reuters) - Regional lender Atlantic Union Bankshares ( AUB ) will buy smaller rival Sandy Spring Bancorp ( SASR ) in a $1.6 billion deal, the companies said on Monday. ...
Novo Nordisk's diabetes pill cuts heart risk by 14% in late-stage study
Novo Nordisk's diabetes pill cuts heart risk by 14% in late-stage study
Oct 21, 2024
Oct 21 (Reuters) - Novo Nordisk said on Monday the oral version of its drug semaglutide, Rybelsus, helped reduce risk of cardiovascular diseases in patients by 14% in a late-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Anil D'Silva) ...
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Oct 21, 2024
Oct 21 (Reuters) - Eli Lilly LLY.N said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. The new lawsuits, which name Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine of Nevada, are the first related to...
Microsoft to allow autonomous AI agent development starting next month
Microsoft to allow autonomous AI agent development starting next month
Oct 21, 2024
By Aditya Soni Oct 21 (Reuters) - Microsoft ( MSFT ) will allow customers to build autonomous artificial intelligence agents starting in November, the software giant said on Monday, in its latest move to tap the booming technology. The company is positioning autonomous agents - programs which require little human intervention unlike chatbots - as apps for an AI-driven world,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved